{"companyId":285098,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"テルックス・ファーマスーティカルズ・リミテッド","headOfficeLocation":"55 フレミントンロード、レベル4 ノースメルボルン、VIC 3051 オーストラリア","presidentName":"クリスチャン・ベーレンブルッフ","companySummary":null,"stockCode":"TLX","currency":"USD","capital":null,"sales":null,"employees":1184,"employeesConsolidated":null,"humanCheck":false,"domains":["telixpharma.com"],"businessContents":["放射性医薬品の開発","がん診断用画像診断および治療製品"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://telixpharma.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}